Coloplast A/S
Coloplast A/S (CLPBY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLPBY · as of Jun 8, 2026
Key Statistics
Explore Coloplast A/S Data
clpby stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 37.5%
The CLPBY analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $14.45, representing +143.27% upside from the current price of $5.94.
Competitors & Peers
clpby competitorsCLPBY
ALPMY
ORINY
SAUHF
SAUHY
SBHMYStock Performance
Full HistoryAbout Coloplast A/S
Coloplast A/S founded in 1954 and headquartered in Humlebæk, Denmark, operates as a global developer and marketer of intimate healthcare products and services. Its extensive reach spans Denmark, the …
what is coloplast a/s · clpby stock overview · coloplast a/s company profile · who is coloplast a/s ceo · clpby OTC · coloplast a/s headquarters · coloplast a/s business segments
About Stock Overview & Key Data
Coloplast A/S (CLPBY) is a Healthcare company in the Medical - Devices industry, listed on OTC since Jan 13, 2014. As of the latest trading session, CLPBY stock price is $5.94, with a market capitalization of $13.4B. The stock has returned -37.87% over the past 12 months and -30.12% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Coloplast A/S stock is Buy, with an average 12-month price target of $14.45. In fiscal year 2025, Coloplast A/S reported revenue of $26.3B and net income of $3.4B. For detailed data — including Coloplast A/S revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Coloplast A/S (CLPBY) stock price is $5.94. The stock is traded on OTC under the ticker symbol CLPBY. The 52-week range is $5.88 – $10.03.